Tetralogic Pharmaceuticals Corp (OTCMKTS:TLOG) shares crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.07 and traded as low as $0.09. Tetralogic Pharmaceuticals shares last traded at $0.09, with a volume of 1,201 shares trading hands.
The stock has a 50-day moving average price of $0.07 and a 200-day moving average price of $0.04.
About Tetralogic Pharmaceuticals (OTCMKTS:TLOG)
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells.
Featured Story: How to Use the New Google Finance Tool
Receive News & Ratings for Tetralogic Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tetralogic Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.